Developer docs
API playgroundTry for free, no card

Search company profiles

Molsoft

Full company profile

uuid000frla

Namestring
Molsoft
Legal namestring
Molsoft L.L.C.
Websiteurl
molsoft.com
Company typeenum
Private
Founded yearint
1994
Descriptiontext

Molsoft L.L.C. is a privately held, founder-controlled computational drug discovery software and services company headquartered in San Diego, California. Founded in 1994 by Ruben Abagyan (originally as Biosoft, renamed 1995), the company develops the proprietary ICM (Internal Coordinate Mechanics) platform, a physics-based molecular modeling framework that operates in internal coordinate space rather than Cartesian coordinates, enabling approximately 1,000x faster convergence for conformational optimization versus traditional methods. ICM serves as the foundation for a modular product portfolio spanning molecular modeling (ICM-Pro), cheminformatics (ICM-Chemist, ICM-Chemist-Pro, MolCart, ICM-Scarab), ML-based target profiling (MolScreen with ~2,500 models across 1,200 targets), and a growing suite of GPU-accelerated tools for ultra-large library virtual screening (GINGER, RIDGE, RIDE, CombiRIDGE, V-SYNTHES, GigaSearch, GigaScreen). Newer AI-native additions released in 2025-2026 include groupGen (generative R-group design) and Ligand AIDE (de novo ligand generation), alongside the RTCNN graph-neural-network scoring function.

The company monetizes through annual software subscriptions (ICM-Pro floating and node-locked licenses, separate GPU add-on modules for GINGER/RIDGE/RIDE), free-tier funnel tools (ICM-Browser, ActiveICM, iMolView, IcmJS), and fee-for-service or FTE-based contract research for drug discovery projects, including cloud-based high-throughput virtual screening on AWS, Azure, and Google Cloud. Molsoft sells primarily into pharmaceutical and biotechnology companies (notably Novartis with ~1,500 global users via the FOCUS collaboration, plus Eilean Therapeutics, Lomond Therapeutics, Arrakis Therapeutics, Rempex/Medicines Company, Aurigene Oncology, Syngene International), with secondary demand from academic institutions (USC, UCSD labs) and government agencies (NIH/NCI). Distribution combines direct enterprise field sales, regional channel partners (Advent Informatics in India, inCerebro in Korea), and a multi-channel marketing apparatus spanning user group meetings, scientific conferences, webinars, technical publications, and a YouTube/community-forum presence.

The company's technology is validated by repeated wins in independent D3R Grand Challenges (2017, 2018, 2020), an OpenEye/Merck/GSK docking competition win, a Pasteur Institute virtual screening comparison, and one FDA-approved drug (Vabomere, 2017) discovered using ICM-based structure design. With 11-50 employees, no documented outside investment, and a 31-year operating history, Molsoft operates as a focused, founder-led specialist serving a technically demanding segment of computational chemistry and structure-based drug design.

Short descriptiontext

MolSoft is a privately held San Diego-based developer of ICM, a physics-based and AI-enhanced molecular modeling platform serving pharmaceutical and biotech companies, academic institutions, and government research agencies through software licensing, GPU-accelerated screening tools, and contract research services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
computational drug discovery, molecular modeling software, virtual ligand screening, cheminformatics tools, structure-based drug design
Industry2 codes
PRIMARYHLAGAJAE
Cheminformatics & Molecular Modeling / CADD
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code3 codes
  • Software Publishers5132
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Computational Drug Discovery Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Software Licensing
TypeSubscription Recurring
Description

MolSoft licenses ICM software products including ICM-Pro, ICM-Chemist, ICM-Browser, and various add-on modules. Licenses are available as floating (server-based, multi-user) or node-locked (single machine). Options include annual, multi-year, perpetual, site, and teaching licenses. GPU-specific license keys available for GINGER, RIDGE, and RIDE modules.

molsoft.com
2GPU License Add-ons
TypeSubscription Recurring
Description

Specialized GPU license keys for accelerated computing tasks including molecular dynamics, RIDE-GPU, RIDGE-GPU, and GINGER. These are add-on licenses to regular ICM-Pro licenses.

molsoft.com
3Contract Research Services
TypeProfessional Services
Description

Fee-for-service or FTE-based consulting services for drug discovery including virtual screening, protein modeling, lead optimization, cheminformatics solutions, and software development. Services are tailored to customer needs and undertaken in-house by expert research scientists.

molsoft.com
4Cloud Computing Services
TypeManaged Services
Description

Virtual screening services run on cloud infrastructure (AWS, Azure, Google Cloud) when extra capacity is needed beyond on-premise capabilities.

molsoft.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details5 tiers
1ICM-Pro Desktop Modeling License
ModelSubscriptionBilling cadenceAnnual
Notes

Core desktop modeling software with molecular modeling, docking, and virtual screening capabilities. License types include floating (multi-user) and node-locked (single machine) options.

molsoft.com
2GPU Accelerated Modules (GINGER, RIDGE, RIDE-GPU)
ModelSubscriptionBilling cadenceAnnual
Notes

Add-on GPU license keys for accelerated conformer generation, docking, and screening. Requires ICM-Pro base license.

molsoft.com
3ICM-Browser (Free)
ModelFreemiumBilling cadenceMulti-year contract
Notes

Free perpetual license for browsing molecules and making interactive 3D documents. No cost, unlimited use.

molsoft.com
4Academic/Teaching Licenses
ModelSubscriptionBilling cadenceAnnual
Notes

Special discounted licensing options for academic institutions and educational use.

molsoft.com
5Contract Research Services
ModelHybridBilling cadencePay-as-you-go
Notes

Fee-for-service or FTE-based pricing models for drug discovery consulting projects. Tailored to specific project scope and duration.

molsoft.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Molsoft develops and licenses the ICM (Internal Coordinate Mechanics) software platform for computational drug discovery, offering tools for molecular modeling, flexible docking, virtual ligand screening, protein homology modeling, and cheminformatics. The platform is sold as ICM-Pro with add-on modules (VLS, Homology, GINGER, RIDGE, RIDE, CombiRIDGE, V-SYNTHES, MolScreen) and standalone cheminformatics products (ICM-Chemist, MolCart, ICM-Scarab), plus contract research and consulting services for pharmaceutical, biotech, academic, and government customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Achieved Ki values below 1nM in multiple drug discovery projects for oncology targets
+4 more records
Product overview1 text field

MolSoft offers a comprehensive platform-plus-modules architecture centered on its proprietary ICM (Internal Coordinate Mechanics) technology. The core ICM-Pro desktop modeling software serves as the primary platform, with specialized modules including the Virtual Ligand Screening (VLS) Module, Homology Module, and ICM-Bio extending its capabilities. Specialized add-on products like GINGER (GPU-accelerated conformer generation), RIDGE (GPU docking), CombiRIDGE (combinatorial docking), GigaScreen (deep learning screening), and V-SYNTHES (synthon-based screening) target ultra-large library virtual screening workflows. Standalone cheminformatics products include ICM-Chemist/Pro, MolCart with Giga-Search, and ICM-Scarab. Free tools encompass ICM-Browser, ActiveICM, IcmJS, and iMolView mobile app. AI-powered additions include groupGen (generative R-group optimization), Ligand AIDE (de novo ligand design), RTCNN scoring function, and MolScreen (ML screening models). The portfolio serves academic labs and pharmaceutical/biotech companies across computational biology and chemistry workflows.

Product and service25 records
1ICM-Pro Desktop Modeling
CategoryMolecular modeling software
Description

MolSoft's main desktop modeling software providing tools for molecular modeling using Biased Probability Monte Carlo and Molecular Dynamics, flexible docking, virtual ligand screening, homology modeling, and structure-based drug design for pharmaceutical, biotech, and academic researchers.

2ICM-Pro Virtual Ligand Screening (VLS) Module
CategoryVirtual screening software
Description

Add-on module enabling high-throughput structure- and ligand-based virtual screening of multi-million and ultra-large compound libraries on a local server or cloud, for pharmaceutical and biotech discovery teams.

3ICM-Pro Homology Module
CategoryProtein modeling software
Description

Add-on module for searching homologs, building structure-based sequence alignments, and creating single- and multi-chain homology models including loops for structural biology researchers.

4ICM-Bio
CategoryBioinformatics software
Description

Add-on module providing an environment for sequence analysis, alignments, profiles, databases, and connectivity with 3D structures with an alignment editor and annotator for bioinformatics users.

5ICM-Chemist
CategoryCheminformatics software
Description

Standalone suite for chemical drawing and editing, chemical database generation, chemical searching, clustering, and enumeration for medicinal chemists and cheminformatics teams.

6ICM-Chemist-Pro
CategoryCheminformatics software
Description

Standalone product containing 3D chemical tools, chemical superposition, 3D interactive ligand-receptor editing, and QSAR modeling for advanced medicinal chemistry users.

7MolCart
CategoryCheminformatics database
Description

Chemical cartridge enabling storage and searching of large chemical compound libraries using a fast relational database for cheminformatics and screening workflows.

8MolCart Giga-Search
CategoryChemical search software
Description

Add-on module enabling substructure and fingerprint search of billions of chemicals in seconds for ultra-large libraries such as Enamine REAL and ZINC database.

9ICM-Scarab
CategoryScientific data management software
Description

Standalone software for storing and disseminating scientific data with tools for data mining, extraction, insertion, and a built-in electronic lab notebook for research organizations.

10MolScreen
CategoryAI/ML screening models
Description

Add-on module providing a set of high-quality 2D fingerprint and 3D AI/ML models for approximately 2,500 pharmacology and toxicology targets across 1,200 targets, used for lead discovery or counter-screening.

11ICM-Browser
CategoryMolecular visualization software
Description

Free downloadable software for browsing molecules and creating fully-interactive 3D molecule documents for embedding in PowerPoint and on the Web, for academic and individual users.

12ActiveICM
CategoryMolecular visualization plugin
Description

Free plugin for viewing and displaying 3D ICM graphical slides and animations in Microsoft PowerPoint and web browsers without plugins, for scientists and educators.

13IcmJS (JavaScript Molecular Viewer)
CategoryWeb-based molecular viewer
Description

JavaScript/HTML5 3D molecular viewer requiring no plugin or browser extension, bringing desktop-quality graphics to web applications with Google Drive integration.

14iMolView Mobile App
CategoryMobile molecular viewer
Description

Mobile app for iPhone/iPad and Android enabling browsing of protein, DNA, and drug molecules in 3D with direct links to PDB and DrugBank for scientists, students, and educators.

15GINGER Conformer Generator
CategoryGPU-accelerated conformer generator
Description

GPU-accelerated neural-network conformer generator add-on module producing high-quality 3D conformations at 150-200 mol/sec on a single RTX 4090 GPU for medicinal chemists and screening teams.

16RIDGE Rapid Docking GPU Engine
CategoryGPU-accelerated docking software
Description

Add-on module enabling structure-based screening of ultra-large libraries with approximately 100-fold speed increase over CPU docking, processing ~100 compounds per second per GPU.

17GPU-RIDE Rapid Isostere Discovery Engine
CategoryGPU ligand-based screening software
Description

GPU-accelerated add-on module for enhanced ligand-based virtual screening using Atomic Property Fields, searching approximately 0.5 million conformers per second per GPU.

18CombiRIDGE Combinatorial Docking
CategoryCombinatorial docking software
Description

GPU-accelerated high-throughput combinatorial anchored docking add-on module that grows R-groups around a defined core fragment using neural networks for ultra-large chemical library screening.

19GigaScreen Deep Learning Screening
CategoryDeep learning screening software
Description

Deep learning virtual screening add-on module combining ML and deep learning tools to tackle the computational intensity of screening very large chemical databases.

20V-SYNTHES Hierarchical Virtual Screening
CategorySynthon-based screening software
Description

Add-on module providing a hierarchical, synthon-based virtual screening strategy for efficiently navigating gigascale make-on-demand chemical libraries by iteratively assembling and docking scaffold-synthon combinations.

21groupGen Generative R-group Optimization
CategoryGenerative AI for drug design
Description

Generative AI add-on module proposing R-group substitutions tailored to specific protein binding sites using 3D graph neural networks, for medicinal chemistry lead optimization.

22Ligand AIDE De Novo Ligand Design
CategoryGenerative AI for drug design
Description

AI-driven evolutionary add-on workflow for de novo ligand generation that iteratively grows and optimizes compounds over multiple generations using generative substitutions and re-docking.

23RTCNN Scoring Function
CategoryNeural network scoring function
Description

Radial and Topological Convolutional Neural Network scoring add-on module combining 2D topological and 3D radial convolutions for improved ligand-receptor binding pose ranking and affinity prediction.

24ICM Molecular Dynamics
CategoryMolecular dynamics software
Description

Molecular dynamics simulation add-on module integrated into ICM-Pro, with GPU acceleration available for enhanced performance.

25Contract Research and Drug Discovery Services
CategoryContract research services
Description

Fee-for-service or FTE-based drug discovery consulting delivered by in-house research scientists, including virtual screening, lead optimization, protein modeling, cheminformatics solutions, and custom software development for pharmaceutical and biotech clients.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-06
Description

Partnership to unlock XtalPi's VAST Space (4.66 billion synthetically accessible compounds) for 3D docking using MolSoft's CombiRIDGE platform. Combines MolSoft's computational screening technology with XtalPi's highly curated, synthesis-aware chemical space. Enables researchers to transition computationally identified hits to experimentally testable compounds in weeks.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-05-20
Description

Korean partner that organized and delivered ICM-Pro Drug Discovery Workshop in Seoul (May 2026). Provides local hands-on training and expanding research collaboration in Korea.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-09-17
Description

ChemSpace used MolSoft ICM suite to successfully complete CACHE 2 Challenge, screening 176 billion chemicals for COVID target NSP13 helicase. Demonstrates robustness of MolSoft technology for ultra-large library screening.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-19
Description

Partnership to make LCC's 1.4 Billion ultra-large, stereo-defined, diverse chemical library available for virtual screening. LCC's chirally pure, sp3-rich scaffolds converted to 3D using GINGER and screened via RIDGE and RIDE methods. Enables structure-based and ligand-based lead discovery.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-03-28
Description

Collaboration to prepare Enamine's REAL database (2 billion+ chemicals) for virtual screening using RIDE method. Enables screening of 48 billion chemical conformers from Enamine REAL database. Partnership maintained during Ukraine crisis.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-05-06
Description

Collaboration to make NIH's Synthetically Accessible Virtual Inventory (SAVI) database containing 1+ billion chemicals available for screening using RIDE method. Includes development of GPU-accelerated screening methods that led to discovery of hits against K-Ras G12D and PD-L1.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-01-15
Description

Integration of Mcule's ULTIMATE library (100+ million novel compounds) into ICM-Chemist and ICM-Pro. Enables 2D and 3D pharmacophore searches, substructure searches, and virtual screening for novel chemistry discovery.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2020-06-15
Description

Distribution agreement for India market. Advent Informatics promotes and distributes ICM computational drug discovery software in India using marketing expertise and research capabilities. Provides local support for Indian customers.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2015-06-11
Description

Over 8-year collaboration developing FOCUS platform - a global communication and modeling environment for medicinal chemists. Novartis has ~1,500 registered users globally. FOCUS based on ICM technology and includes ICM Ligand Editor for structure-based design.

10Biovitrum AB
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration with Biovitrum AB (Sweden) to co-develop the BeeHive Cheminformatics Client System. Product used by Biovitrum and Structural Genomics Consortium as program manager and database interface.

molsoft.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Oncology-focused biotech company using MolSoft's AI and physics-based molecular modeling tools as integral part of Loch Company Group. Multiple compounds (eiletoclax, lomonotinib, balamenib) have entered clinical trials.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Developer of StarDrop and related software for drug discovery, including ADMET prediction, multi-parameter optimization, and small molecule design. Directly comparable to Molsoft in cheminformatics, lead optimization, and decision-support for medicinal chemistry.

TypeDirect peer
Description

Computational chemistry and molecular design software company offering ligand-based and structure-based tools (Flare, Spark, Torch). Directly comparable to Molsoft in ligand-based virtual screening, 3D pharmacophore modeling, and field-based methods for medicinal chemistry.

TypeBroad incumbent
Description

Scientific R&D software platform covering data management, chemistry, and biology informatics. Listed alongside Molsoft as a key chemoinformatics player; broader scope as a full scientific R&D platform rather than a focused molecular modeling tool.

TypeBroad incumbent
Description

Dassault's life sciences software portfolio including BIOVIA Discovery Studio and pipeline of scientific R&D tools. Overlaps with Molsoft in molecular modeling, virtual screening, and cheminformatics, but is part of a much broader enterprise PLM/Scientific portfolio serving multiple industries.

TypeDirect peer
Description

Developer of the Molecular Operating Environment (MOE) and related drug discovery software. Directly comparable to Molsoft's ICM-Pro in desktop molecular modeling, docking, virtual screening, and QSAR for pharma and academic customers.

TypeDirect peer
Description

Cheminformatics software platform providing chemical search, structure handling, and molecular informatics tools. Directly comparable to Molsoft in cheminformatics and chemical database management, with broader enterprise footprint and partnerships with large pharma IT systems.

TypeDirect peer
Description

Public computational chemistry and molecular simulation software company offering physics-based and AI-driven drug discovery platforms. Directly comparable to Molsoft in molecular modeling, docking, virtual screening, and cheminformatics serving pharmaceutical and biotech customers, with broader product breadth and a significantly larger R&D budget.

TypeEmerging player
Description

AI-driven drug discovery company combining physics-based modeling with AI and a synthesis-aware compound space (VAST). Both partner and adjacent competitor to Molsoft in computational drug discovery and ultra-large library screening.

TypeBroad incumbent
Description

Life sciences informatics and software division of Revvity (formerly PerkinElmer), offering Signals platforms for chemistry, biology, and translational R&D. Broad incumbent with overlapping cheminformatics and drug discovery software offerings.

TypeDirect peer
Description

Provider of molecular modeling and cheminformatics software (OEChem, OEDocking, Orion) for drug discovery. Directly comparable to Molsoft's ICM suite across virtual screening, cheminformatics, and molecular design, now backed by Cadence's enterprise scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration8 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Molsoft

Computational Drug Discovery Softwaremolsoft.com

MolSoft is a privately held San Diego-based developer of ICM, a physics-based and AI-enhanced molecular modeling platform serving pharmaceutical and biotech companies, academic institutions, and government research agencies through software licensing, GPU-accelerated screening tools, and contract research services.

What Molsoft does

Molsoft L.L.C. is a privately held, founder-controlled computational drug discovery software and services company headquartered in San Diego, California. Founded in 1994 by Ruben Abagyan (originally as Biosoft, renamed 1995), the company develops the proprietary ICM (Internal Coordinate Mechanics) platform, a physics-based molecular modeling framework that operates in internal coordinate space rather than Cartesian coordinates, enabling approximately 1,000x faster convergence for conformational optimization versus traditional methods. ICM serves as the foundation for a modular product portfolio spanning molecular modeling (ICM-Pro), cheminformatics (ICM-Chemist, ICM-Chemist-Pro, MolCart, ICM-Scarab), ML-based target profiling (MolScreen with ~2,500 models across 1,200 targets), and a growing suite of GPU-accelerated tools for ultra-large library virtual screening (GINGER, RIDGE, RIDE, CombiRIDGE, V-SYNTHES, GigaSearch, GigaScreen). Newer AI-native additions released in 2025-2026 include groupGen (generative R-group design) and Ligand AIDE (de novo ligand generation), alongside the RTCNN graph-neural-network scoring function.

The company monetizes through annual software subscriptions (ICM-Pro floating and node-locked licenses, separate GPU add-on modules for GINGER/RIDGE/RIDE), free-tier funnel tools (ICM-Browser, ActiveICM, iMolView, IcmJS), and fee-for-service or FTE-based contract research for drug discovery projects, including cloud-based high-throughput virtual screening on AWS, Azure, and Google Cloud. Molsoft sells primarily into pharmaceutical and biotechnology companies (notably Novartis with ~1,500 global users via the FOCUS collaboration, plus Eilean Therapeutics, Lomond Therapeutics, Arrakis Therapeutics, Rempex/Medicines Company, Aurigene Oncology, Syngene International), with secondary demand from academic institutions (USC, UCSD labs) and government agencies (NIH/NCI). Distribution combines direct enterprise field sales, regional channel partners (Advent Informatics in India, inCerebro in Korea), and a multi-channel marketing apparatus spanning user group meetings, scientific conferences, webinars, technical publications, and a YouTube/community-forum presence.

The company's technology is validated by repeated wins in independent D3R Grand Challenges (2017, 2018, 2020), an OpenEye/Merck/GSK docking competition win, a Pasteur Institute virtual screening comparison, and one FDA-approved drug (Vabomere, 2017) discovered using ICM-based structure design. With 11-50 employees, no documented outside investment, and a 31-year operating history, Molsoft operates as a focused, founder-led specialist serving a technically demanding segment of computational chemistry and structure-based drug design.

Molsoft firmographics

Firmographics
Name
Molsoft
Legal name
Molsoft L.L.C.
Website
https://molsoft.com
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
1–10 employees
Short description
MolSoft is a privately held San Diego-based developer of ICM, a physics-based and AI-enhanced molecular modeling platform serving pharmaceutical and biotech companies, academic institutions, and government research agencies through software licensing, GPU-accelerated screening tools, and contract research services.
Ownership category
akta.pro rank

Molsoft industry classification

Industry
Product category
Computational Drug Discovery Software
NAICS
Software Publishers (5132), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAJAE
Cheminformatics & Molecular Modeling / CADD
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Computational drug discovery
  • Molecular modeling software
  • Virtual ligand screening
  • Cheminformatics tools
  • Structure-based drug design

Where Molsoft is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Molsoft business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Software Licensing: MolSoft licenses ICM software products including ICM-Pro, ICM-Chemist, ICM-Browser, and various add-on modules. Licenses are available as floating (server-based, multi-user) or node-locked (single machine). Options include annual, multi-year, perpetual, site, and teaching licenses. GPU-specific license keys available for GINGER, RIDGE, and RIDE modules.
  2. GPU License Add-ons: Specialized GPU license keys for accelerated computing tasks including molecular dynamics, RIDE-GPU, RIDGE-GPU, and GINGER. These are add-on licenses to regular ICM-Pro licenses.
  3. Contract Research Services: Fee-for-service or FTE-based consulting services for drug discovery including virtual screening, protein modeling, lead optimization, cheminformatics solutions, and software development. Services are tailored to customer needs and undertaken in-house by expert research scientists.
  4. Cloud Computing Services: Virtual screening services run on cloud infrastructure (AWS, Azure, Google Cloud) when extra capacity is needed beyond on-premise capabilities.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualICM-Pro Desktop Modeling License
SubscriptionAnnualGPU Accelerated Modules (GINGER, RIDGE, RIDE-GPU)
FreemiumMulti-year contractICM-Browser (Free)
SubscriptionAnnualAcademic/Teaching Licenses
HybridPay-as-you-goContract Research Services

Go-to-market motion3 records

Distribution channels5 records

Marketing channels10 records

Molsoft product offering

Product offering

Core offering

Molsoft develops and licenses the ICM (Internal Coordinate Mechanics) software platform for computational drug discovery, offering tools for molecular modeling, flexible docking, virtual ligand screening, protein homology modeling, and cheminformatics. The platform is sold as ICM-Pro with add-on modules (VLS, Homology, GINGER, RIDGE, RIDE, CombiRIDGE, V-SYNTHES, MolScreen) and standalone cheminformatics products (ICM-Chemist, MolCart, ICM-Scarab), plus contract research and consulting services for pharmaceutical, biotech, academic, and government customers.

Product overview

MolSoft offers a comprehensive platform-plus-modules architecture centered on its proprietary ICM (Internal Coordinate Mechanics) technology. The core ICM-Pro desktop modeling software serves as the primary platform, with specialized modules including the Virtual Ligand Screening (VLS) Module, Homology Module, and ICM-Bio extending its capabilities. Specialized add-on products like GINGER (GPU-accelerated conformer generation), RIDGE (GPU docking), CombiRIDGE (combinatorial docking), GigaScreen (deep learning screening), and V-SYNTHES (synthon-based screening) target ultra-large library virtual screening workflows. Standalone cheminformatics products include ICM-Chemist/Pro, MolCart with Giga-Search, and ICM-Scarab. Free tools encompass ICM-Browser, ActiveICM, IcmJS, and iMolView mobile app. AI-powered additions include groupGen (generative R-group optimization), Ligand AIDE (de novo ligand design), RTCNN scoring function, and MolScreen (ML screening models). The portfolio serves academic labs and pharmaceutical/biotech companies across computational biology and chemistry workflows.

Differentiator

Problem solved

Functional benefit

Products and services

  • ICM-Pro Desktop Modeling MolSoft's main desktop modeling software providing tools for molecular modeling using Biased Probability Monte Carlo and Molecular Dynamics, flexible docking, virtual ligand screening, homology modeling, and structure-based drug design for pharmaceutical, biotech, and academic researchers.
  • ICM-Pro Virtual Ligand Screening (VLS) Module Add-on module enabling high-throughput structure- and ligand-based virtual screening of multi-million and ultra-large compound libraries on a local server or cloud, for pharmaceutical and biotech discovery teams.
  • ICM-Pro Homology Module Add-on module for searching homologs, building structure-based sequence alignments, and creating single- and multi-chain homology models including loops for structural biology researchers.
  • ICM-Bio Add-on module providing an environment for sequence analysis, alignments, profiles, databases, and connectivity with 3D structures with an alignment editor and annotator for bioinformatics users.
  • ICM-Chemist Standalone suite for chemical drawing and editing, chemical database generation, chemical searching, clustering, and enumeration for medicinal chemists and cheminformatics teams.
  • ICM-Chemist-Pro Standalone product containing 3D chemical tools, chemical superposition, 3D interactive ligand-receptor editing, and QSAR modeling for advanced medicinal chemistry users.
  • MolCart Chemical cartridge enabling storage and searching of large chemical compound libraries using a fast relational database for cheminformatics and screening workflows.
  • MolCart Giga-Search Add-on module enabling substructure and fingerprint search of billions of chemicals in seconds for ultra-large libraries such as Enamine REAL and ZINC database.
  • ICM-Scarab Standalone software for storing and disseminating scientific data with tools for data mining, extraction, insertion, and a built-in electronic lab notebook for research organizations.
  • MolScreen Add-on module providing a set of high-quality 2D fingerprint and 3D AI/ML models for approximately 2,500 pharmacology and toxicology targets across 1,200 targets, used for lead discovery or counter-screening.
  • ICM-Browser Free downloadable software for browsing molecules and creating fully-interactive 3D molecule documents for embedding in PowerPoint and on the Web, for academic and individual users.
  • ActiveICM Free plugin for viewing and displaying 3D ICM graphical slides and animations in Microsoft PowerPoint and web browsers without plugins, for scientists and educators.
  • IcmJS (JavaScript Molecular Viewer) JavaScript/HTML5 3D molecular viewer requiring no plugin or browser extension, bringing desktop-quality graphics to web applications with Google Drive integration.
  • iMolView Mobile App Mobile app for iPhone/iPad and Android enabling browsing of protein, DNA, and drug molecules in 3D with direct links to PDB and DrugBank for scientists, students, and educators.
  • GINGER Conformer Generator GPU-accelerated neural-network conformer generator add-on module producing high-quality 3D conformations at 150-200 mol/sec on a single RTX 4090 GPU for medicinal chemists and screening teams.
  • RIDGE Rapid Docking GPU Engine Add-on module enabling structure-based screening of ultra-large libraries with approximately 100-fold speed increase over CPU docking, processing ~100 compounds per second per GPU.
  • GPU-RIDE Rapid Isostere Discovery Engine GPU-accelerated add-on module for enhanced ligand-based virtual screening using Atomic Property Fields, searching approximately 0.5 million conformers per second per GPU.
  • CombiRIDGE Combinatorial Docking GPU-accelerated high-throughput combinatorial anchored docking add-on module that grows R-groups around a defined core fragment using neural networks for ultra-large chemical library screening.
  • GigaScreen Deep Learning Screening Deep learning virtual screening add-on module combining ML and deep learning tools to tackle the computational intensity of screening very large chemical databases.
  • V-SYNTHES Hierarchical Virtual Screening Add-on module providing a hierarchical, synthon-based virtual screening strategy for efficiently navigating gigascale make-on-demand chemical libraries by iteratively assembling and docking scaffold-synthon combinations.
  • groupGen Generative R-group Optimization Generative AI add-on module proposing R-group substitutions tailored to specific protein binding sites using 3D graph neural networks, for medicinal chemistry lead optimization.
  • Ligand AIDE De Novo Ligand Design AI-driven evolutionary add-on workflow for de novo ligand generation that iteratively grows and optimizes compounds over multiple generations using generative substitutions and re-docking.
  • RTCNN Scoring Function Radial and Topological Convolutional Neural Network scoring add-on module combining 2D topological and 3D radial convolutions for improved ligand-receptor binding pose ranking and affinity prediction.
  • ICM Molecular Dynamics Molecular dynamics simulation add-on module integrated into ICM-Pro, with GPU acceleration available for enhanced performance.
  • Contract Research and Drug Discovery Services Fee-for-service or FTE-based drug discovery consulting delivered by in-house research scientists, including virtual screening, lead optimization, protein modeling, cheminformatics solutions, and custom software development for pharmaceutical and biotech clients.

Quantifiable outcome

  • Achieved Ki values below 1nM in multiple drug discovery projects for oncology targets
  • +4 more outcomes

Companies that use Molsoft

Customer profile

Named customers11 records

Segments4 records

Ideal customer profiles4 records

Molsoft technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability7 records

Feature10 records

Molsoft partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • XtalPicoreStrategic or Co-development Partner · 6 June 2026Partnership to unlock XtalPi's VAST Space (4.66 billion synthetically accessible compounds) for 3D docking using MolSoft's CombiRIDGE platform. Combines MolSoft's computational screening technology with XtalPi's highly curated, synthesis-aware chemical space. Enables researchers to transition computationally identified hits to experimentally testable compounds in weeks.
  • inCerebro Co., Ltd.minorChannel Partner/ Reseller/ Distributor · 20 May 2025Korean partner that organized and delivered ICM-Pro Drug Discovery Workshop in Seoul (May 2026). Provides local hands-on training and expanding research collaboration in Korea.
  • ChemSpaceminorStrategic or Co-development Partner · 17 September 2024ChemSpace used MolSoft ICM suite to successfully complete CACHE 2 Challenge, screening 176 billion chemicals for COVID target NSP13 helicase. Demonstrates robustness of MolSoft technology for ultra-large library screening.
  • Liverpool Chiro Chem (LCC)coreStrategic or Co-development Partner · 19 April 2024Partnership to make LCC's 1.4 Billion ultra-large, stereo-defined, diverse chemical library available for virtual screening. LCC's chirally pure, sp3-rich scaffolds converted to 3D using GINGER and screened via RIDGE and RIDE methods. Enables structure-based and ligand-based lead discovery.
  • EnaminecoreStrategic or Co-development Partner · 28 March 2022Collaboration to prepare Enamine's REAL database (2 billion+ chemicals) for virtual screening using RIDE method. Enables screening of 48 billion chemical conformers from Enamine REAL database. Partnership maintained during Ukraine crisis.
  • NIH/NCIcoreStrategic or Co-development Partner · 6 May 2021Collaboration to make NIH's Synthetically Accessible Virtual Inventory (SAVI) database containing 1+ billion chemicals available for screening using RIDE method. Includes development of GPU-accelerated screening methods that led to discovery of hits against K-Ras G12D and PD-L1.
  • MculeminorStrategic or Co-development Partner · 15 January 2021Integration of Mcule's ULTIMATE library (100+ million novel compounds) into ICM-Chemist and ICM-Pro. Enables 2D and 3D pharmacophore searches, substructure searches, and virtual screening for novel chemistry discovery.
  • Advent InformaticscoreChannel Partner/ Reseller/ Distributor · 15 June 2020Distribution agreement for India market. Advent Informatics promotes and distributes ICM computational drug discovery software in India using marketing expertise and research capabilities. Provides local support for Indian customers.
  • NovartiscoreStrategic or Co-development Partner · 11 June 2015Over 8-year collaboration developing FOCUS platform - a global communication and modeling environment for medicinal chemists. Novartis has ~1,500 registered users globally. FOCUS based on ICM technology and includes ICM Ligand Editor for structure-based design.
  • Biovitrum ABminorStrategic or Co-development PartnerCollaboration with Biovitrum AB (Sweden) to co-develop the BeeHive Cheminformatics Client System. Product used by Biovitrum and Structural Genomics Consortium as program manager and database interface.
  • Eilean TherapeuticscoreStrategic or Co-development PartnerOncology-focused biotech company using MolSoft's AI and physics-based molecular modeling tools as integral part of Loch Company Group. Multiple compounds (eiletoclax, lomonotinib, balamenib) have entered clinical trials.

Scale indicators7 records

Recent moves9 records

Expansion highlights4 records

Molsoft competitors and assessment

Company assessment

Direct peers

  • Optibrium: Developer of StarDrop and related software for drug discovery, including ADMET prediction, multi-parameter optimization, and small molecule design. Directly comparable to Molsoft in cheminformatics, lead optimization, and decision-support for medicinal chemistry.
  • Cresset: Computational chemistry and molecular design software company offering ligand-based and structure-based tools (Flare, Spark, Torch). Directly comparable to Molsoft in ligand-based virtual screening, 3D pharmacophore modeling, and field-based methods for medicinal chemistry.
  • Chemical Computing Group (CCG): Developer of the Molecular Operating Environment (MOE) and related drug discovery software. Directly comparable to Molsoft's ICM-Pro in desktop molecular modeling, docking, virtual screening, and QSAR for pharma and academic customers.
  • ChemAxon: Cheminformatics software platform providing chemical search, structure handling, and molecular informatics tools. Directly comparable to Molsoft in cheminformatics and chemical database management, with broader enterprise footprint and partnerships with large pharma IT systems.
  • Schrödinger: Public computational chemistry and molecular simulation software company offering physics-based and AI-driven drug discovery platforms. Directly comparable to Molsoft in molecular modeling, docking, virtual screening, and cheminformatics serving pharmaceutical and biotech customers, with broader product breadth and a significantly larger R&D budget.
  • OpenEye Scientific (Cadence Design Systems): Provider of molecular modeling and cheminformatics software (OEChem, OEDocking, Orion) for drug discovery. Directly comparable to Molsoft's ICM suite across virtual screening, cheminformatics, and molecular design, now backed by Cadence's enterprise scale.

Broad incumbents

  • Dotmatics: Scientific R&D software platform covering data management, chemistry, and biology informatics. Listed alongside Molsoft as a key chemoinformatics player; broader scope as a full scientific R&D platform rather than a focused molecular modeling tool.
  • BIOVIA (Dassault Systèmes): Dassault's life sciences software portfolio including BIOVIA Discovery Studio and pipeline of scientific R&D tools. Overlaps with Molsoft in molecular modeling, virtual screening, and cheminformatics, but is part of a much broader enterprise PLM/Scientific portfolio serving multiple industries.
  • Revvity Signals: Life sciences informatics and software division of Revvity (formerly PerkinElmer), offering Signals platforms for chemistry, biology, and translational R&D. Broad incumbent with overlapping cheminformatics and drug discovery software offerings.

Emerging players

  • XtalPi: AI-driven drug discovery company combining physics-based modeling with AI and a synthesis-aware compound space (VAST). Both partner and adjacent competitor to Molsoft in computational drug discovery and ultra-large library screening.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Molsoft social profiles

Digital presence

Molsoft financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Molsoft leadership team

Management profile

Number of profiles

Profiles3 records

Molsoft funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Molsoft M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Molsoft

What does Molsoft do?

Molsoft develops and licenses the ICM (Internal Coordinate Mechanics) software platform for computational drug discovery, offering tools for molecular modeling, flexible docking, virtual ligand screening, protein homology modeling, and cheminformatics. The platform is sold as ICM-Pro with add-on modules (VLS, Homology, GINGER, RIDGE, RIDE, CombiRIDGE, V-SYNTHES, MolScreen) and standalone cheminformatics products (ICM-Chemist, MolCart, ICM-Scarab), plus contract research and consulting services for pharmaceutical, biotech, academic, and government customers.

Is Molsoft a public or private company?

Molsoft is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Molsoft founded?

Molsoft was founded in 1994. It employs 1 to 10 people.

Where is Molsoft based?

Molsoft is headquartered in San Diego, United States, in the North America region.

How does Molsoft make money?

Four revenue lines are on record. Software Licensing is the primary driver. The others are GPU License Add-ons, contract Research Services and cloud Computing Services.

Who are Molsoft's main competitors?

Direct peers on record are Optibrium, Cresset, Chemical Computing Group (CCG), ChemAxon, Schrödinger and OpenEye Scientific (Cadence Design Systems). Broad incumbents are Dotmatics, BIOVIA (Dassault Systèmes) and Revvity Signals. XtalPi is listed as an emerging player.

Does Molsoft have an API?

No public API is recorded for Molsoft.

What industry is Molsoft in?

Molsoft's product category is Computational Drug Discovery Software. Its primary akta.pro industry code is HLAGAJAE, Cheminformatics & Molecular Modeling / CADD, with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 5132 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals